Figures & data
Figure 1 Study design and selection of participants, including initial target for number of respondents.
![Figure 1 Study design and selection of participants, including initial target for number of respondents.](/cms/asset/ed687c66-2d72-4e84-9b53-93ab5f6c8bdf/dndt_a_175188_f0001_b.jpg)
Table 1 Comparison of baseline demographic characteristics and baseline patient-reported scores for US and UK MDD samples
Table 2 Response frequency distributions and descriptive statistics for PDQ-D items at baseline
Table 3 Internal consistency reliability: PDQ-D scale-level properties at baseline for US and UK MDD samples
Table 4 Convergent validity: Pearson correlation coefficients between baseline PDQ-D subscale and total scores and baseline scores from other survey measures in the US and UK study populations with MDD
Table 5 Mean comparison across MDD and general populations for testing known-groups validity of baseline PDQ-D total and subscale scores
Figure 3 Known-groups validity: mean baseline PDQ-D subscale and total scores for the MDD and general populations: (A) US sample; (B) UK sample. *P<0.001 vs general population sample.
![Figure 3 Known-groups validity: mean baseline PDQ-D subscale and total scores for the MDD and general populations: (A) US sample; (B) UK sample. *P<0.001 vs general population sample.](/cms/asset/b660691d-8c12-4517-a29f-583bbe3c8cd3/dndt_a_175188_f0003_b.jpg)
Table 6 Responsiveness to change: Comparison of mean changes from baseline in PDQ-D subscale and total scores for respondents with MDD as a function of their classification based on worsening, no change, or improvement from baseline to follow-up in PHQ-9 score